Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early bactericidal activity and pharmacokinetics of Contezolid in drug-resistant pulmonary tuberculosis
ChiCTR2300074581Phase 4Not yet recruiting
- Sponsor
- Shenzhen Third People's Hospital
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of contezolid and linezolid in pulmonary tuberculosis (TB) (3 arms), sponsored by Shenzhen Third People's Hospital. Primary endpoint: Early bactericidal activity of Contezolid. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
contezolidlinezolid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR2300074581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074581.